Recent advances in self-expanding stents for use in the superficial femoral and popliteal arteries

Arash Aghel, Ehrin J. Armstrong

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Significant advances have been made in femoropopliteal stent design and clinical outcomes during the past decade. Initial randomized studies demonstrated superiority of nitinol self-expanding stents to balloon angioplasty for treatment of moderate-length superficial femoral artery stenoses. During longer-term follow-up, first generation nitinol stents were hampered by high rates of stent fracture. A number of newer nitinol stent designs have been developed with improved conformability, greater radial strength and lower rates of long-term stent fracture. These newer stent designs have demonstrated superior primary patency and decreased restenosis for the treatment of moderate-length femoropopliteal lesions relative to historical benchmarks. Recent advances in drug-eluting nitinol stents have also offered treatment options for challenging lesion subsets including very long femoropopliteal lesions and for the treatment of in-stent restenosis. This article reviews recent advances and upcoming research in nitinol self-expanding stent technology for the treatment of superficial femoral and popliteal artery stenosis.

Original languageEnglish (US)
Pages (from-to)833-842
Number of pages10
JournalExpert Review of Cardiovascular Therapy
Volume12
Issue number7
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Popliteal Artery
Femoral Artery
Stents
Pathologic Constriction
Therapeutics
Benchmarking
Drug-Eluting Stents
Balloon Angioplasty
nitinol
Technology

Keywords

  • claudication
  • nitinol stents
  • peripheral artery disease
  • popliteal artery
  • randomized trials
  • restenosis
  • stent
  • superficial femoral artery

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine
  • Medicine(all)

Cite this

Recent advances in self-expanding stents for use in the superficial femoral and popliteal arteries. / Aghel, Arash; Armstrong, Ehrin J.

In: Expert Review of Cardiovascular Therapy, Vol. 12, No. 7, 2014, p. 833-842.

Research output: Contribution to journalArticle

@article{a6a503e4804e4f1998440ee205c02796,
title = "Recent advances in self-expanding stents for use in the superficial femoral and popliteal arteries",
abstract = "Significant advances have been made in femoropopliteal stent design and clinical outcomes during the past decade. Initial randomized studies demonstrated superiority of nitinol self-expanding stents to balloon angioplasty for treatment of moderate-length superficial femoral artery stenoses. During longer-term follow-up, first generation nitinol stents were hampered by high rates of stent fracture. A number of newer nitinol stent designs have been developed with improved conformability, greater radial strength and lower rates of long-term stent fracture. These newer stent designs have demonstrated superior primary patency and decreased restenosis for the treatment of moderate-length femoropopliteal lesions relative to historical benchmarks. Recent advances in drug-eluting nitinol stents have also offered treatment options for challenging lesion subsets including very long femoropopliteal lesions and for the treatment of in-stent restenosis. This article reviews recent advances and upcoming research in nitinol self-expanding stent technology for the treatment of superficial femoral and popliteal artery stenosis.",
keywords = "claudication, nitinol stents, peripheral artery disease, popliteal artery, randomized trials, restenosis, stent, superficial femoral artery",
author = "Arash Aghel and Armstrong, {Ehrin J.}",
year = "2014",
doi = "10.1586/14779072.2014.918505",
language = "English (US)",
volume = "12",
pages = "833--842",
journal = "Expert Review of Cardiovascular Therapy",
issn = "1477-9072",
publisher = "Expert Reviews Ltd.",
number = "7",

}

TY - JOUR

T1 - Recent advances in self-expanding stents for use in the superficial femoral and popliteal arteries

AU - Aghel, Arash

AU - Armstrong, Ehrin J.

PY - 2014

Y1 - 2014

N2 - Significant advances have been made in femoropopliteal stent design and clinical outcomes during the past decade. Initial randomized studies demonstrated superiority of nitinol self-expanding stents to balloon angioplasty for treatment of moderate-length superficial femoral artery stenoses. During longer-term follow-up, first generation nitinol stents were hampered by high rates of stent fracture. A number of newer nitinol stent designs have been developed with improved conformability, greater radial strength and lower rates of long-term stent fracture. These newer stent designs have demonstrated superior primary patency and decreased restenosis for the treatment of moderate-length femoropopliteal lesions relative to historical benchmarks. Recent advances in drug-eluting nitinol stents have also offered treatment options for challenging lesion subsets including very long femoropopliteal lesions and for the treatment of in-stent restenosis. This article reviews recent advances and upcoming research in nitinol self-expanding stent technology for the treatment of superficial femoral and popliteal artery stenosis.

AB - Significant advances have been made in femoropopliteal stent design and clinical outcomes during the past decade. Initial randomized studies demonstrated superiority of nitinol self-expanding stents to balloon angioplasty for treatment of moderate-length superficial femoral artery stenoses. During longer-term follow-up, first generation nitinol stents were hampered by high rates of stent fracture. A number of newer nitinol stent designs have been developed with improved conformability, greater radial strength and lower rates of long-term stent fracture. These newer stent designs have demonstrated superior primary patency and decreased restenosis for the treatment of moderate-length femoropopliteal lesions relative to historical benchmarks. Recent advances in drug-eluting nitinol stents have also offered treatment options for challenging lesion subsets including very long femoropopliteal lesions and for the treatment of in-stent restenosis. This article reviews recent advances and upcoming research in nitinol self-expanding stent technology for the treatment of superficial femoral and popliteal artery stenosis.

KW - claudication

KW - nitinol stents

KW - peripheral artery disease

KW - popliteal artery

KW - randomized trials

KW - restenosis

KW - stent

KW - superficial femoral artery

UR - http://www.scopus.com/inward/record.url?scp=84903196677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903196677&partnerID=8YFLogxK

U2 - 10.1586/14779072.2014.918505

DO - 10.1586/14779072.2014.918505

M3 - Article

C2 - 24830846

AN - SCOPUS:84903196677

VL - 12

SP - 833

EP - 842

JO - Expert Review of Cardiovascular Therapy

JF - Expert Review of Cardiovascular Therapy

SN - 1477-9072

IS - 7

ER -